Table 3. Comparison of PiCCO2 parameters between Control and enhanced external counterpulsation (EECP) groups after return of spontaneous circulation (ROSC).
| Group | Baseline | ROSC 1 h | ROSC 2 h | ROSC 3 h | ROSC 4 h |
|---|---|---|---|---|---|
| PCCO (L/min) | |||||
| Control | 3.4±0.2 | 2.0±0.7 | 1.2±0.1 | 1.9±0.3 | 1.8±0.1 |
| EECP | 3.3±0.3 | 2.1±0.5 | 2.8±0.3*** | 2.4±0.3** | 2.3±0.2** |
| SV (mL) | |||||
| Control | 17.9±0.9 | 12.6±4.3 | 12.2±2.9 | 11.9±2.1 | 8.1±0.6 |
| EECP | 18.0±0.3 | 17.6±3.6*** | 17.2±1.7*** | 14.6±1.7*** | 13.4±1.1*** |
| SVR (dyn*s*cm-5) | |||||
| Control | 4209.2±164.8 | 4080.2±2186.8 | 10597.8±7579.6 | 7714.1±1032.5 | 7238.6±558.8 |
| EECP | 4165.9±205.4 | 3881.0±514.2** | 3498.8±422.5*** | 4593.9±669.9*** | 5095.7±517.2*** |
| DPMX (mmHg/s) | |||||
| Control | 1489.4±190.7 | 933.0±58.3 | 585.5±38.1 | 686.2±57.5 | 717.0±43.8 |
| EECP | 1483.0±274.6 | 951.3±48.2 | 993.3±65.1*** | 1036.1±96.3*** | 1128.5±51.3*** |
| CO (L/m) | |||||
| Control | 3.5±0.4 | 2.1±0.5 | 1.4±0.2 | 1.4±0.3 | 1.8±0.5 |
| EECP | 3.4±0.6 | 2.8±0.3* | 2.0±0.6*** | 1.7±0.2*** | 2.8±0.7*** |
| GEDV (mL) | |||||
| Control | 198.0±15.3 | 143.0±9.0 | 140.0±25.8 | 181.1±16.9 | 188.0±19.9 |
| EECP | 198.5±13.1 | 198.0±0.0*** | 219.4±25.6*** | 226.3±19.4** | 238.2±33.2*** |
| ITBV (mL) | |||||
| Control | 247.6±3.9 | 247.0±0.0 | 273.7±19.7 | 272.6±61.6 | 235.1±41.2 |
| EECP | 250.0±9.8 | 278.8±11.2** | 295.0±18.6** | 296.4±51.2*** | 285.0±61.8*** |
| EVLW (mL) | |||||
| Control | 136.7±1.2 | 145.5±54.3 | 346.5±44.9 | 342.4±28.3 | 248.6±46.5 |
| EECP | 135.0±3.8 | 153.6±10.3* | 157.0±32.4*** | 159.6±21.1*** | 160.0±39.1*** |
| PVPI | |||||
| Control | 2.7±0.8 | 3.7±0.7 | 6.5±2.3 | 6.3±1.1 | 6.3±1.4 |
| EECP | 2.9±0.5 | 3.3±0.5* | 4.5±1.2** | 3.5±0.4*** | 3.3±0.9*** |
| GEF (%) | |||||
| Control | 35.0±0.2 | 35.2±1.1 | 20.5±3.7 | 20.4±1.5 | 20.3±2.6 |
| EECP | 34.0±0.5 | 36.6±1.3 | 37.0±5.2*** | 29.9±7.1** | 27.0±1.7*** |
| ScvO2 (%) | |||||
| Control | 80.1±2.4 | 60.3±10.6 | 62.5±6.1 | 67.6±7.5 | 70.9±6.4 |
| EECP | 80.1±1.8 | 80.0±4.1*** | 85.1±0.9*** | 82.7±1.5*** | 75.1±2.8** |
| DO2 (mL/min.m2) | |||||
| Control | 731.6±41.1 | 658.6±154.4 | 594.7±98.6 | 408.4±76.2 | 279.5±23.8 |
| EECP | 725.8±44.1 | 702.4±119.7 | 669.4±64.9** | 569.2±65.2** | 542.3±45.2*** |
| VO2 (mL/min.m2) | |||||
| Control | 101.5±19.4 | 321.7±104.9 | 289.4±50.6 | 272.2±9.7 | 161.7±25.0 |
| EECP | 104.6±12.3 | 280.8±39.7** | 269.6±8.5* | 249.8±61.5** | 114.2±19.3*** |
PCCO: pulse contour cardiac output; SV: stroke volume; SVR: systemic vascular resistance; DPMX: maximum rate of increase in pressure; CO: cardiac output; GEDV: global end-diastolic volume; ITBV: intrathoracic blood volume; EVLW: extravascular lung water; PVPI: pulmonary vascular permeable index; GEF: global ejection fraction; ScvO2: central venous oxygen saturation; DO2: oxygen delivery; VO2: oxygen consumption. Data are reported as means±SD. **P<0.05, **P<0.01, ***P<0.001 EECP group vs Control group (t-test).